1. EP-2356: Inter-observer variability in OAR and target volume delineation in curative prostate cancer patients. (April 2018) Authors: Tiigi, K.; Tiigi, R.; Oro, I.; Adamson, M.; Kolk, K.; Põldveer, M. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S1232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Gender‐specific co‐activation of arginine vasopressin and the hypothalamic–pituitary–adrenal axis during stress. (20th October 2014) Authors: Kacheva, S.; Kolk, K.; Morgenthaler, N.G.; Brabant, G.; Karges, W. Journal: Clinical endocrinology Issue: Volume 82:Number 4(2015:Apr.) Page Start: 570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Gender‐specific co‐activation of arginine vasopressin and the hypothalamic–pituitary–adrenal axis during stress. (20th October 2014) Authors: Kacheva, S.; Kolk, K.; Morgenthaler, N.G.; Brabant, G.; Karges, W. Journal: Clinical endocrinology Issue: Volume 82:Number 4(2015:Apr.) Page Start: 570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PH-0484: Evaluation of AI based contouring tools in prostate cancer RT. (November 2020) Authors: Borkvel, A.; Gershkevitsh, E.; Adamson, M.; Kolk, K.; Zolotuhhin, D. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗